
Integer Holdings (ITGR) Stock Forecast & Price Target
Integer Holdings (ITGR) Analyst Ratings
Bulls say
Integer Holdings is a leading player in the medical device component industry, with a strong presence in the lucrative US market as well as in other regions. Despite lowering its full-year guidance, the company remains confident in its long-term growth potential, with a focus on strengthening its core EP market and exploring strategic options for increased value creation. The company's recent decline in stock price presents a buying opportunity for investors looking for a durable and undervalued franchise in the medtech industry.
Bears say
Integer Holdings is facing several challenges, including a decline in revenue and EPS in the second quarter due to lower sales in Cardio & Vascular and Other Markets, as well as the pending sale to a private-equity firm. This is further highlighted by the company's decision to withdraw financial guidance for the year and the lower revenue and EPS estimates for 2026. The divested Electrochem division and ongoing operational investments may also impact the company's profitability in the short term, and the company's recent stock performance and revised price target suggest concerns about its outlook.
This aggregate rating is based on analysts' research of Integer Holdings and is not a guaranteed prediction by Public.com or investment advice.
Integer Holdings (ITGR) Analyst Forecast & Price Prediction
Start investing in Integer Holdings (ITGR)
Order type
Buy in
Order amount
Est. shares
0 shares